Pascal RONFARD

Founder of SOLACTIS SAS, Pascal RONFARD has positioned the company since 2013 as a leader of food and feed ingredients, active on the microbiota. This positioning has been rewarded by highly sought regulatory recognitions: two European (EFSA) and one South Korean (MFDS) official health claims. In 2015, SOLACTIS SAS has located its R&D center in the renowned Science Campus INRAe, near Paris. Since 2021, SOLACTIS SAS is part of the Greentech Group and is the Food&Feed Ingredients Division, with a product offering enlarged to micro-algae, bacteria strains and plant extracts.

Mr. Ronfard is President of the Professional Group “HEC- Agroindustry”, and member of the board of Club PAI. Mr. Ronfard is a graduate of the HEC Business School and holds a Master degree in Corporate Law, from Paris II University.

J.J. Lin

Lamiaa Ahmed

Gut microbiota modulation as a promising therapy with metformin in rats with non-alcoholic steatohepatitis: Role of LPS/TLR4 and autophagy pathways

Dr. Jeremy Everett

Jeremy Everett is the Professor of Pharmaceutical Technologies at the University of Greenwich UK and Visiting Professor in the Faculty of Medicine at Imperial College. Jeremy conducts research in metabolic profiling. He is a co-discoverer of pharmacometabonomics, which is the prediction of drug effects prior to dosing via analysis of pre-dose metabolic profiles. His current work is focused on genotype – metabotype correlations in the areas of obesity and ageing and he is a co-inventor on a recently filed patent on an anti-obesogenic agent.

Jeremy received his BSc and PhD in chemistry from Nottingham University, UK. He did post-doctoral studies at McMaster University and at McGill University in Canada. Jeremy is a Fellow of the Royal Society of Chemistry and a Chartered Chemist, a Member of the American Chemical Society and is an author or co-author on over 100 peer-reviewed publications and patents, with over 5,300 citations to date and an h-index of 31. 

Elias Hakalehto

Title : Bacteriological Intestinal Balance

E. Elias Hakalehto, PhD, graduated from the University of Helsinki as a microbiologist in 1983. In 1995 he received the Postgraduate Diploma in Biotechnology from Canterbury and London, U.K. He is an alumnus of University College London in biochemical engineering. His R&D company Finnoflag Oy (est.1993) has carried out over 100 projects for various industries and universities. He was nominated year 2008 as an Adjunct Professor of biotechnical microbe analytics in Kuopio (nowadays University of Eastern Finland), and an Adjunct Professor for the University of Helsinki in 2016 in microbiological agroecology. Year 2015 he became the vice president of the International Society of Environmental Indicators, chairing the global 22nd ICEI conference in Helsinki 2017. Dr. Hakalehto has edited several scientific books on microbiome, hygiene maintenance, etc. His inventions include the Portable Microbe Enrichment Unit (PMEU), Bacteriological Intestinal Balance (BIB) and novel biorefineries. He is the Fellow Member of the International Society for Development and Sustainability (ISDS) (Japan).

Prof. Mario Guslandi

Mario Guslandi graduated in Medicine and specialized in Gastroenterology at the  State University of Milan. He has been research fellow and  Medical Assistant at the Institute of Internal Medicine of University of Milan from 1978 to 1990. In 1990 he moved to S.Raffaele Hospital of Milan, where he has been  Head of the Clinical Hepato-Gastroenterology Unit from 1991 to 2016. Since January 2017 he is Consultant  Gastroenterologist at San Raffaele Hospital.  He is also Adjunt Professor at both  the  School of Medicine and the Post-graduate School in  Gastroenterology of the S.Raffaele University of Milan. Dr Guslandi is a Fellow of the American College of Gastroenterology and a member of the British Society of Gastroentero­logy.  He is author of more than 500 scientific papers, most of which appeared in international medical journals and parti­cipated as a speaker in various international congresses and symposia.

Dr. Shahram Lavasani

Dr. Shahram Lavasani is an international keynote speaker and entrepreneur in the field of the microbiome. He received his PhD in Immunology from Lund University in Sweden while studying the immunoregulation and immunotherapies in multiple sclerosis (MS). With more than two decades of teaching and research expertise on Gut-Brain axis, he has pioneered research in MS by demonstrating gut inflammation and barrier dysfunction and introduced microbiota-based therapies using probiotic bacterial consortia. He is the founder of ImmuneBiotech developing novel microbiome therapeutics. The company has access to a proprietary lactobacilli library and advanced selection technologies to design nutritional formulations for optimal management of the diseases. ImmuneBiotech´s first product GutMagnific© has been designed to address the underlying causes of IBS and successfully launched to European market in October 2019.

Katrine Whiteson

Dr. Katrine Whiteson is an Assistant Professor at University of California Irvine and the co-Director of the UCI Microbiome Center  She studied Biochemistry at UC Berkeley (BA, 2000) and University of Chicago (PhD, 2007). She first had the opportunity to study human-associated microbes at the University of Geneva Hospitals in 2008. Her lab at UCI studies the human microbiome in health and disease. This has them hunting for bacteria, fungi and viruses in feces, sewage, sputum and other well-loved samples - the students are brave! She will present findings from collaborations with Professors Jen Martiny and Julia Sewell to run a high fiber diet intervention at UC Irvine, and with Cal State Fullerton Anthropologist John Patton to study microbiomes from Conambo, Ecuador. Their favorite study designs are longitudinal, and they use metabolomics and sequencing along with in vitro culturing and experimental evolution to study human microbiomes.

Oliver Worsley

Martina Aulitto

Dr. Martina Aulitto obtained her MSc (Biology) from the University of Naples Federico II and her PhD (Biotechnology) from the University of Naples Federico II. She is previously worked in the field of molecular biology of archaeal viruses. Her PhD research was based on the exploitation of thermophilic microorganisms and their enzymes for lignocellulosic biomass conversion into value-added products. She currently works as post-doc researcher on the eco-friendly isolation of nanocellulose from agri-foods, a versatile building block for the production of food ingredients, edible coatings and flame retardants.

Patrizia Contursi

Prof. Patrizia Contursi obtained her MSc (Biology) from the University Federico II,Napoli and her PhD (Biochemistry and Molecular Biology) from the University Federico II,Napoli. She is previously worked in the field of Biochemistry, Molecular Biology of Archaea in collaboration with University of Copenhagen. Her PhD research was based on developing of genetic systems for the archaeon Sulfolobus solfataricus. She currently lectures Biochemistry at the University of Napoli Federico II. Her area of interest is biotechnological exploitation of thermophilic microrganisms. She has published 44 papers in peer reviewed journals.

Lucía Diez Gutiérrez

Lucía Diez-Gutiérrez has a degree in Biological Science by the University of Oviedo (Spain, 2012-2016). Then, she achieved a double Master´s degree in Biotechnology of Environment and Health by the University of Oviedo (Spain, 2016-2017) and an MSc Food Chain Systems by Cranfield University (United Kingdom, 2017-2018). Since 2018, she is doing her PhD thesis in Tecnalia Research & Innovation, focusing on the development of new functional foods using by-products through fermentation techniques. During this time, she has been working with probiotics trying to enhance the production of beneficial microbial metabolites known as postbiotics.

Amr T. M. Saeb

Prof. Saeb earned my PhD (Molecular Phylogenetics and Population Genetics) from The Ohio State University, USA, in 2006. 25+ years of experience in different countries. my research interest is focused on but not limited to molecular genetics, complex disease genetics and evolution, diabetes genetics, bacterial pathogenomics and virulence, molecular pathology, microbiome, and host-pathogen interactions. He Delivered lectures in world-class scientific conferences in China, the UK, Netherlands, Austria, and Spain (European Congress of Clinical Microbiology and Infectious Diseases and Welcome Genome Campus). He authored 52 total publications in international peer-review journals, mostly as first-author, and reached 444 citations and counting. 

Di Pierro

Jean-Philippe KUNZ

Heather Holmes

Pauliina Halimaa

Jonathan Tanaka

Mauricio Agudelo

CE. MAURICIO AGUDELO obtained his BSc (Chemical engineering) from the University of Antioquia. He has been a serial entrepreneur for the last 10 years. He currently run a biotech startup company named Bialtec focus in redefine the animal nutrition supporting the production of animal protein antibiotic free. His areas of interest are biotechnology, precision animal nutrition, machine learning. He has published a poster and a paper in peer reviewed journals.

Alessandra Cervino

Dr. Benjamin Anderschou Holbech Jensen

Dr. Jensen obtained his Ph.D. (Molecular Biomedicine) from the University of Copenhagen and then spent +3 three years in Canada. After this stay, and a few patents and a spinout company later, he returned to Denmark to set up a group as head of the Nutritional Immunology Lab, Department of Biomedical Sciences, Copenhagen. His lab is committed to bridge the current knowledge gaps in how dietary factors, gut microbial community structures, and compartmentalized immunology synergizes to orchestrate host immunometabolism of both gastrointestinal and extra-intestinal origin. They develop and use experimental systems tailored to model human disease with unmet medical needs; both to improve our molecular understanding of disease progression and to identify hierarchical factors of therapeutic relevance. The lab has a particular interest in host defense peptides and their influence on host-microbe mutualism at the onset, prevention, and treatment of immune/metabolic dysfunctions. Apart from his daytime job as lab head, Dr. Jensen is deeply involved in several international expert groups, just as he is a frequently used consultant for several top-notch biotech companies.

Erika Gilmandinova

Ajith Nair

Dr. Ajith Nair has dedicated the last 20 years of his 30 years of industrial research experience to the development of innovative methods improving the drug stabilization process. His experience also includes extensive work on extending FDA recommended QbD Process to the drug stabilization process. He is the inventor of the first scientific packaging development and sensitivity profiling method for solid oral drugs known as Liveo Optima.

He established and managed two world-class R&D centers in Singapore and the USA. These centers focus on providing professional packaging research services to the pharmaceutical industry. Dr. Nair holds 14 patents and 10 scientific publications. He has an MS in Physical and Polymer Chemistry and a Ph.D. in Surface Chemistry.

Dana Buckman

Applying almost 30 years of flow cytometry experience in cancer and autoimmune research to developing new assays in microbial analysis.   Leveraging expertise in multicolor flow cytometry and cell sorting for the probiotic industry. Dana worked as a senior scientist for Pfizer before forming Flow Paradigm in 2012 and nano-Bioforms in 2014 which became BioForm Solutions in 2016. Dana earned two degrees, one in BioChemistry and the other in Molecular, Cellular, Developmental Biology at the University of Colorado. Dana is a certified flow cytometrist (ICCE) and is a member of the Southern California Flow Cytometry Association, serving on the program committee for the annual summit since 2016.  Dana is also a member of IPA and serves on the technical and education committees.

Caroline de Freitas

Caroline de Freitas obtained her BSc (Biotechnology) from the Federal University of São Carlos and her MSc (Applied Microbiology) from the São Paulo State University and its currently attending PhD (Applied Microbiology) in São Paulo State University. In her Ph.D. research, she intends to purify/isolate XOS by its degree of polymerization using molecular exclusion chromatography and evaluate their individual potential for the growth of probiotic bacteria. In addition, the production of metabolites produced by XOS fermentation will be evaluated.

Nur A. Hasan

Dr. Nur A Hasan is a molecular microbiologist with decade of experience in microbial genomics, bioinformatics, microbiome, infectious disease diagnosis and public health.  Dr. Hasan is an accomplished Executive with experience in strategic development of technology innovation in the biotechnology, pharmaceutical, and life science industries.  Dr. Hasan is the Chief Executive Officer of EzBiome Inc. Before joining EzBiome, Dr. Hasan was the Chief Scientific Officer at CosmosID and Adjunct Professor at the Center for Bioinformatics and Computational Biology, University of Maryland. Dr. Hasan received his Bachelor and Master’s in Microbiology, M.B.A in Marketing and Ph.D. in Genomics. In his multidisciplinary research experience, Dr. Hasan led various independent large-scale genomic, metagenomic research projects in the field of infectious communicable diseases, microbiome and biomarker discovery that resulted in multiple patents and over 100 peer-reviewed articles, 100+ abstracts and conference proceedings, and over 60 scientific presentations in national and international conferences. Dr. Hasan has professionally served at various prestigious scientific panels including WHO, ASM, NCBI and ISO, and at the Editorial Board of multiple peer-reviewed scientific journals. Currently, Dr. Hasan directs the strategic leadership and scientific functions of EzBiome Inc., a microbiome company which applies precision taxonomy discovery platform to shorten the time for discovery and development of companion diagnostics, and therapeutics biomarkers for microbiome-related diseases.

Dr. Michel Brienzo

Gaurav Kaushik

Cristina Stewart Bogsan

Prof. Sophia Eugenia Martínez Vázquez

Dr. Marcos Antonio de Morais Junior

Dr. Marcos A. Morais Jr obtained his BSc (Biology) from the Federal University of Pernambuco and his PhD (Biochemistry/Molecular Biology) from the Federal University of Rio Grande do Sul. He had experiences in molecular biotechnology at GBF/Germany and in industrial microbiology at TU Delft/The Netherlands. He currently lectures basic genetics, genetic engineering and metabolic engineering at the Federal University of Pernambuco. His area of interest is industrial biotechnology, including basic aspects of fermentation, quantitative physiology, genetic and metabolic engineering and functional genomics, with the aim to identify, select and improve yeasts and lactic acid bacteria. He conducts technical consultancies for companies in the biofuels, beverages and probiotics sectors and has published more than 120 papers in peer reviewed journals.

Dr. Kui Zhu

Dr. Kui Zhu is a professor at National Center for Veterinary Drug Safety Evaluation, College of Veterinary Medicine, China Agricultural University (CAU). He obtained the Doctor degree from Ludwig Maximilians University Munich (LMU Munich) in Germany. After that, he did his postdoc training at Duke University in the U.S. Since Sept. 2016, he moved back to China and started his research at CAU. His group mainly focuses on antibacterial target identification and antibiotic discovery to combat multi-drug resistant bacterial pathogens. In the past five years, more than 20 publications have been published in Nature Microbiology, Lancet Infectious Disease, Advanced Science and other high impact journals.

Prof. Concetta Finocchiaro

Maria Karolina Szmidt

Vishal Singh

Vishal Singh is an Assistant Professor of Nutritional Physiology and Microbiome at The Pennsylvania State University. Dr. Singh’s ‘Nutrition and Microbiome’ lab aims to solve the health issues faced by consuming processed foods and the health implications of fortifying refined dietary fiber(s) in packaged foods. Specifically, his lab is currently focusing on harnessing the power of fermentable dietary fibers (FDFs) to correct gut microbiota dysbiosis, and addressing the following questions: (i) Is the fortification of refined FDFs in processed food ‘good’ for all humans? (ii) If not, which groups are likely to have adverse effects from the consumption of refined FDFs such as inulin? His recent work answered a longstanding puzzle of why patients with inflammatory bowel disease report poor tolerance to certain dietary fibers (Gut, 2019). The vision of his lab is to develop microbiome-informed dietary fiber interventions to improve gastrointestinal and metabolic health. Dr. Singh’s research is supported by Crohn’s and Colitis Foundation.

Javier Mauricio Agudelo Rendon

Mr. Mauricio Agudelo is a Chemical Engineer from the University of Antioquia. He previuosly worked in Colanta (one of the biggest animal feed industries in Colombia) where he decided to aim his professional efforts in animal nutrition. He founded two start-ups both oriented in producing sustainable ways for food and feed. He is coinventor of two patents. His areas of interest are eubiotics, metagenomics, artificial intelligence and animal nutrition.

Hariom Yadav

Hariom Yadav, PhD, assistant professor of internal medicine in the section of molecular medicine at Wake Forest School of Medicine. His research focuses on gut-brain axis contributing in the pathology of aging-related diseases such as diabetes, obesity and Alzheimer’s disease. Dr. Yadav seeks to prevent or delay these conditions by modulating the gut microbiome and reducing low-grade inflammation. His lab is developing novel probiotics and dietary fibers to treat leaky gut, which contributes to low grade inflammation. 

Leaky gut, where microbial ingredients such as lipopolysaccharides and antigens leak out from the gut and stimulate low-grade inflammation, is the target of much of Yadav’s research activity. Yadav and his team are working to on- (i) novel probiotics made from dead bacteria, (ii) drugs like metformin and (iii) have discovered a new kind of dietary fiber; that can reduce leaky gut. He is researching holistic delivery methods, where natural remedies such as probiotics/ prebiotics/ postbiotics/ synbiotics can be added to foods to benefit people’s health and hopes to develop their translational potential by initiating clinical studies. Another aspect of Yadav’s research is investigating the interactions of microbiome with the many types of cells present in the human gut. Those interactions impact signaling communication between the gut and the brain. With deeper understanding of that communication, Yadav believes that more targeted and effective therapies can be developed for conditions when signaling is disrupted, such as obesity and Alzheimer’s disease. Yadav also studies various diets and how they impact the microbiome, potentially to the benefit of health. He is assessing how the Mediterranean diet and the ketogenic diet may impact Alzheimer’s disease. He is also involved with a clinical trial looking at how exercise, dietary restriction and drugs (metformin) change the microbiome and affect leaky gut. A technology developed in his lab is licensed for commercialization with Postbiotics Inc. Dr. Yadav have developed an state-of-art ‘Microbiome-Suite’ consisting microbiome sequencing, bioinformatics analyses, growth of aerobic and anaerobic bacteria, fecal microbiota transplantation and housing of germ-free mice. These facilities are available for collaborations with intramural investigators and industrial partners. The overall goal of Dr. Yadav’s research program is to develop gut microbiome based markers and therapies to reduce aging-related disorders and improve health-span in older adults.

Lina Toro

To be updated soon...

Peter Leighton

Peter Leighton is the CEO of ProSperity Bioscience, and founding partner of Abunda Functional Foods, an integrated consulting group. Leighton brings 30+ years’ experience in consumer products, nutraceuticals and biotechnology. Responsible for some of the most successful brands on the market, Leighton has been a thought leader in the areas of functional foods and science-based nutraceuticals. Leighton has held senior executive positions with Complete Nutrition, Advana Science, Natrol (NTOL), Galileo Laboratories, Metabolife, and Weider Nutrition (WNI).

Dr. Smita Singh

Dr. Smita Singh obtained her BSc (Food Processing Technology) from Birla Institute of Technology, Mesra, Ranchi, Jharkhand, India. She has obtained her M.Sc and Ph.D (Food Science and Technology) from Banaras Hindu University, Varanasi, Uttar Pradesh, India. She has previously worked as Guest lecturer in reputed colleges, freelancer food safety auditor and content writer and as Assistant Professor and HEAD in the Department of Food Technology, Doon (PG) College of Agriculture, Science and Technology, Dehradun, Uttarakhand, India. Her PhD research was based on the “Development of Beta-Glucan fortified spray dried instantized RTS milk beverage powder”. She currently lectures different subjects of Food Technology at the Graphic Era Deemed to be University, Dehradun, Uttarakhand, India. Her area of interest is food fortification, new product development, food quality & safety analysis, enrichment of traditional food products. She has published various papers in peer reviewed journals.

Jacobo Poó Pantoja

Dr. Kristin Neumann

Marie Drago

Erika Gilmandinova

Leah Valente

Angelito Abaoag

Angelito Ortega Abaoag is a molecular microbiologist and specializes on microbiome modulation. He is currently a Senior Scientist in Microbiome Lifesciences Pte Ltd, SINGAPORE. He has more than 30 years of experience in microbial community studies, bioproduct formulations, mixed-culture fermentation, molecular-based testing and biosystems design.

Andrea Echeverry

Prof. Z. Dilek Heperkan

Dr. Mithilesh Jaiswal

Dr. Mithilesh Jaiswal obtained his MSc (Bioscience) and PhD ( Microbiology) from the University of Jabalpur ( India). He is currently working on Probiotic cultures and development of synbiotic products for various Human and animal application. His Ph.D research was based on the Mycoherbicidal potential of different fungi against the biological control of hazardous weed like Parthenium . His area of interest is Probiotics, Starter cultures and Biofertilizers. He has published various papers in peer reviewed journals.

Dunyaporn Trachootham

Dr. Dunyaporn Trachootham obtained her DDS (Dentistry) from Mahidol University, Thailand and her PhD (Biomedical Sciences: pharmacology) from University of Texas Health Sciences Center at Houston, USA. She received graduate certificate in Nutritional Sciences for Health professional from Tuft University, USA. She is an associate professor and the program director of Master of Sciences program in Toxicology and Nutrition for Food Safety at Institute of Nutrition, Mahidol University. She lectures research methodology, toxicology, nutrition, and functional food. Her area of interest is research and development of functional food for health benefits (safety and efficacy aspects). She has published various papers in peer reviewed journals and received over 6,059 citations. She also provides academic service for Thai Food and Drug Administration as an assessor of novel food, genetically modified plant, dietary supplement, food for special purposes and health claims.

Dr. Shakira Ghazanfar

Dr. Shakira Ghazanfar got her Ph. D. degree in 2016 in Microbiology/Animal Probiotic She is working as Senior Scientific Officer, in NIGAB, National Agriculture Research Center, Pakistan since 2010. She was regarded among the pioneers, who have initiated Animal Probiotic research to improve livestock productivity in Pakistan by using local isolated microbial strains. She worked on various projects related to the improve livestock productivity. One of her key projects was She was to develop the Target based Animal Probiotic to Improve Nilli Ravi buffalo Milk Yield in cost effective manner. She has isolated more than 600 bacterial strains from local animal gut and submitted their sequencing in to NCBI.  She initiated the project for the Establishment of NIGAB-Microbial Culture Collection (NMCC) at NARC. MNCC is a microbial gene bank for the preservation of the bacterial strains for future use in teaching, research and industrial application. Currently She has more than 1000 microbial strains in the NMCC including Pediococcus pentosaceus: Involved in the preparation of silage for improve milk yield in hot condition, Bacillus tequilensis: Involved in the preparation of silage for improve milk yield in hot condition, Lactobacillus agilis, Lactobacillus delbrueckii: Main bacteria involved in the production of yogurt; Pediococcus acidilactici, Enterococcus faecalis, Weissella cibaria, Weissella confusa, Weissella bombi, Lactobacillus plantarum, Lactobacillus rhamnosus etc.

At present, her prime research interests are: Target Probiotic preparation by using Next generation sequencing tools; Food Safety (food-borne illness associated pathogens, nano-active packaging), Nano-medicine (multi-drug resistance related diseases). She is an active researcher and produced many publications in well reputed journals and conferences and published many research papers and book chapters and engaged in research supervising multiple students at PhD, Graduate and Under-graduate level

Dr. Prity Singh

I have completed my Ph.D. from Banaras Hindu University, India at the age of 28 years. I have worked on the development of probiotic milk powder and also worked on heavy metal analysis using AAS. Nowadays I am enjoying motherhood, so it’s actually a pause in carrier.

https://www.linkedin.com/in/dr-prity-singh-31576bb1/

Belal J Muhialdin

Dr. Belal J. Muhialdin obtained his Ph.D. (Food Biotechnology) from Universiti Putra Malaysia (UPM). He is previously worked as Post-Doctoral Research Fellow at UPM, and currently, he is appointed as Senior Lecturer at the Department of Food Science, Faculty of Food Science and Technology UPM. His expertise in Food Microbiology with 45 journal publications made on this adjacent topic to date. His research interests emphasize lactic acid bacteria and their contributions to the production of fermented foods, alongside their health benefits for the consumers. Recently, he received International Collaboration Fund in collaboration with the University of Alberta to determine the health benefits of plant-based fermented foods that demonstrated immunomodulation effects in animal models. Dr. Belal applies advanced genetics, ecology, and immune assay techniques to study the common and unique properties of individual strains as well as the functional capacities of food effects of fermented foods on the human gut microbiome. 

Nadiya Boyko

Mounir Adnane

Dr. Mounir Adnane obtained his Surgeon Veterinary Degree from the University of Blida (Algeria), and his Magister and Ph.D. (Veterinary) from the High National Veterinary School of Algiers (Algeria). He is previously worked as a quality control officer for the Ministry of Agriculture and Rural Development in Algeria. He worked also as a Postdoc at University College Dublin and Research Assistant at Trinity College Dublin (Ireland). His Ph.D. research was based on the development of a new technic for the diagnosis of uterine inflammation, by measuring immune active molecules in the cervicovaginal mucus. He currently lectures Cytogenetic and Theriogenology at the University of Tiered (Algeria). His area of interest is the immunology of reproduction, uterine inflammation, genital microbiome, and pheromone production. He has published various papers and reviews in peer-reviewed journals.

Atieh Darbandi

Dr. Atieh Darbandi received his BSc (Bacteriology) from Shahed Medical, the University of Iran, and his Ph.D. (Bacteriology) from the Iran Medical University. I did research at the same time as my studies and I have 6 years of experience working in a medical diagnostic laboratory. I based her doctoral research on the application of genotoxicity and cytotoxicity of probiotics. I am currently working on probiotics at the Iran University of Medical Sciences. I have several articles on this subject.

Dr. Poornachandra Rao K

Amandeep Singh

Mr.Amandeep Singh obtained his D. Pharmacy, B. Pharmacy, and  M. Pharmacy from ISF College of Pharmacy, Moga, Punjab, India. Pursuing his Ph.D. from MRSPTU, Bathinda, Punjab, India.  Currently, he is working as an assistant professor at ISF College of Pharmacy, Moga, Punjab, India. His area of interest including targeted drug delivery systems, nanocarrier.  He has published more than 40 review and research articles in various reputed journals. He has published more than 3 book chapters. He is the editorial team member of various national and international reputed journals. He was the brand ambassador of Bentham science-2020. He has also participated and presented his research work at various national and international conferences.

Dr. Norhafizah Abdullah

Dr. Norhafizah has the academic background in Microbiology (Manchester University), Bioreactor Systems (MSc-Manchester University) and Chemical Engineering (PhD- Cambridge University). Prior to lectureship at the Universiti Putra Malaysia (1998-present), she worked in few commercial laboratories (medical and industrial testing labs). The philosophy underlying her research activities is based on interdisciplinary approach via combining microbiology, biochemistry, chemistry with engineering disciplines for overall bioprocess economic improvement. This covers topics on production and, product design and formulation. Some of her  team's current research projects are product design for probiotic, separation chromatography, nano-encapsulation for control delivery of active biomaterials, application of biological techniques for waste treatment.

Assoc Prof Dr Biswadeep Das

Dr. Meena Somanchi

Dr. Meena Somanchi is a nutritionist with extensive experience in nutrition research, teaching and dietetics. She worked in prestigious institutions such as Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University School of Medicine, Federal government and VA hospital. She also runs a private practice in nutrition counseling in Maryland. Dr. Somanchi has given lectures on nutrition and health at health fairs, senior centers, Doctor’s offices and community centers in Maryland. She has presented her research work at scientific conferences in USA and abroad. Dr.Somanchi has published various papers in peer reviewed journals. She received The Young Scientists Award for Experimental Nutrition from the Nutrition Society of India, She was nominated for the VARS-Rhode lecture award for the work she did at Johns Hopkins University School of Medicine at the American Society for Parenteral and Enteral Nutrition (ASPEN).

Krunal Dholiya

Mr Krunal Dholiya obtained his MSc (Geology) from the Nirma University, India and he is doing his PhD (Biosciences) from the Veer Narmad South Gujarat University, India. He is previously worked for microbial fermentation industry and in academics he taught Applied Microbiology to BSc students. His PhD research was based on the application of competitive antagonism and antimicrobial compound produced by probiotics. Currently, he is Cofounder and R&D Scientist at Framtix Holding, Ab, Sweden. He has published various papers in peer reviewed journals and he has filed a patent on antimicrobial nanocomposite at EPO.

Dr. Asma Kazemi